GENIE & Gene Expression

GENIE (Gene Expression: Inflammation Explained) is a transcriptomic test that measures gene expression to characterize the systemic effects of CIRS. Rather than looking at individual markers, GENIE examines patterns of gene activation that reflect the body's overall response to chronic biotoxin exposure.

One of the key findings in CIRS is a "hypometabolic" pattern — a shift in gene expression that suggests the body's cells are operating in a reduced metabolic state. This pattern may help explain the profound fatigue and cognitive difficulties that many CIRS patients experience, as the cells appear to be functioning at a reduced capacity.

GENIE represents an approach to understanding CIRS as a systems biology problem — looking at how the body's interconnected systems respond to chronic inflammatory activation. By examining gene expression patterns, researchers and practitioners can gain insight into the biological processes driving symptoms, even when individual markers may not tell the full story. This educational content is presented to help patients understand the scientific basis of CIRS, not as diagnostic guidance.